[Inactivated poliovirus vaccine]
- PMID: 21922761
[Inactivated poliovirus vaccine]
Abstract
During the final stage of global polio eradication program, universal use of inactivated poliovirus vaccine (IPV) is the most feasible option to minimize the inherent risk of oral poliovirus vaccine (OPV), such as vaccine-associated paralytic poliomyelitis (VAPP) and polio outbreaks due to vaccine-derived polioviruses. Introduction of diphtheria, pertussis, tetanus, IPV (DPT-IPV) products, instead of OPV, to routine polio immunization should be seriously and urgently considered to minimize ongoing risk of VAPP in Japan. Accordingly, a further polio immunization strategy, including the immunization schedule using DPT-IPV, interchangeability of different DPT-IPV products, intensified polio surveillance activities, and appropriate polio vaccine stockpile, should be developed to maintain polio-free status in Japan prior to the introduction of DPT-IPV.
Similar articles
-
[Universal use of inactivated poliovirus vaccine--the needs and challenges].Nihon Rinsho. 2008 Oct;66(10):1950-5. Nihon Rinsho. 2008. PMID: 18939495 Review. Japanese.
-
World wide experience with inactivated poliovirus vaccine.Vaccine. 2008 Sep 15;26(39):4978-83. doi: 10.1016/j.vaccine.2008.07.026. Epub 2008 Aug 3. Vaccine. 2008. PMID: 18680777 Review.
-
The cost-effectiveness of alternative polio immunization policies in South Africa.Vaccine. 2006 Jul 17;24(29-30):5670-8. doi: 10.1016/j.vaccine.2006.05.032. Vaccine. 2006. PMID: 16766096
-
Cost analysis of post-polio certification immunization policies.Bull World Health Organ. 2004 Jan;82(1):9-15. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106295 Free PMC article.
-
Polio eradication: the OPV paradox.Rev Med Virol. 2003 Sep-Oct;13(5):277-91. doi: 10.1002/rmv.401. Rev Med Virol. 2003. PMID: 12931339 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources